These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20805522)

  • 1. MRS in presymptomatic MAPT mutation carriers: a potential biomarker for tau-mediated pathology.
    Kantarci K; Boeve BF; Wszolek ZK; Rademakers R; Whitwell JL; Baker MC; Senjem ML; Samikoglu AR; Knopman DS; Petersen RC; Jack CR
    Neurology; 2010 Aug; 75(9):771-8. PubMed ID: 20805522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frontal lobe
    Chen Q; Boeve BF; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Haley D; Gunter JL; Graff-Radford J; Jones D; Knopman D; Graff-Radford N; Kraft R; Lapid M; Rademakers R; Syrjanen J; Wszolek ZK; Rosen H; Boxer AL; Kantarci K
    Neurology; 2019 Aug; 93(8):e758-e765. PubMed ID: 31315971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [
    Wolters EE; Papma JM; Verfaillie SCJ; Visser D; Weltings E; Groot C; van der Ende EL; Giannini LAA; Tuncel H; Timmers T; Boellaard R; Yaqub M; van Assema DME; Kuijper DA; Segbers M; Rozemuller AJM; Barkhof F; Windhorst AD; van der Flier WM; Pijnenburg YAL; Scheltens P; van Berckel BNM; van Swieten JC; Ossenkoppele R; Seelaar H
    Neurology; 2021 Sep; 97(10):e1017-e1030. PubMed ID: 34210823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain MR Spectroscopy Changes Precede Frontotemporal Lobar Degeneration Phenoconversion in Mapt Mutation Carriers.
    Chen Q; Boeve BF; Tosakulwong N; Lesnick T; Brushaber D; Dheel C; Fields J; Forsberg L; Gavrilova R; Gearhart D; Haley D; Gunter JL; Graff-Radford J; Jones D; Knopman D; Graff-Radford N; Kraft R; Lapid M; Rademakers R; Wszolek ZK; Rosen H; Boxer AL; Kantarci K
    J Neuroimaging; 2019 Sep; 29(5):624-629. PubMed ID: 31173437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRS shows abnormalities before symptoms in familial Alzheimer disease.
    Godbolt AK; Waldman AD; MacManus DG; Schott JM; Frost C; Cipolotti L; Fox NC; Rossor MN
    Neurology; 2006 Mar; 66(5):718-22. PubMed ID: 16534109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.
    Murray ME; Przybelski SA; Lesnick TG; Liesinger AM; Spychalla A; Zhang B; Gunter JL; Parisi JE; Boeve BF; Knopman DS; Petersen RC; Jack CR; Dickson DW; Kantarci K
    J Neurosci; 2014 Dec; 34(49):16247-55. PubMed ID: 25471565
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Joe E; Medina LD; Ringman JM; O'Neill J
    Brain Imaging Behav; 2019 Aug; 13(4):925-932. PubMed ID: 29907927
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo
    Jones DT; Knopman DS; Graff-Radford J; Syrjanen JA; Senjem ML; Schwarz CG; Dheel C; Wszolek Z; Rademakers R; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Boeve BF
    Neurology; 2018 Mar; 90(11):e947-e954. PubMed ID: 29440563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of 1H-MR spectroscopy and cerebrospinal fluid biomarkers in Alzheimer's disease: diverging behavior at three different brain regions.
    Bittner DM; Heinze HJ; Kaufmann J
    J Alzheimers Dis; 2013; 36(1):155-63. PubMed ID: 23579327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated imaging of [
    Ratai EM; Alshikho MJ; Zürcher NR; Loggia ML; Cebulla CL; Cernasov P; Reynolds B; Fish J; Seth R; Babu S; Paganoni S; Hooker JM; Atassi N
    Neuroimage Clin; 2018; 20():357-364. PubMed ID: 30112276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-MK-6240 tau-PET in genetic frontotemporal dementia.
    Levy JP; Bezgin G; Savard M; Pascoal TA; Finger E; Laforce R; Sonnen JA; Soucy JP; Gauthier S; Rosa-Neto P; Ducharme S
    Brain; 2022 Jun; 145(5):1763-1772. PubMed ID: 34664612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early anterior cingulate involvement is seen in presymptomatic MAPT P301L mutation carriers.
    Clarke MTM; St-Onge F; Beauregard JM; Bocchetta M; Todd E; Cash DM; Rohrer JD; Laforce R
    Alzheimers Res Ther; 2021 Feb; 13(1):42. PubMed ID: 33568215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Critical Proton MR Spectroscopy Marker of Alzheimer's Disease Early Neurodegenerative Change: Low Hippocampal NAA/Cr Ratio Impacts APOE ɛ4 Mexico City Children and Their Parents.
    Calderón-Garcidueñas L; Mora-Tiscareño A; Melo-Sánchez G; Rodríguez-Díaz J; Torres-Jardón R; Styner M; Mukherjee PS; Lin W; Jewells V
    J Alzheimers Dis; 2015; 48(4):1065-75. PubMed ID: 26402110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between hippocampal volumes and proton magnetic resonance spectroscopy of the posterior cingulate gyrus and hippocampi in Alzheimer's disease.
    Park EJ; Lyra KP; Lee HW; Caramelli P; Otaduy MCG; Leite CC
    Dement Neuropsychol; 2010; 4(2):109-113. PubMed ID: 29213672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations.
    Whitwell JL; Jack CR; Boeve BF; Senjem ML; Baker M; Ivnik RJ; Knopman DS; Wszolek ZK; Petersen RC; Rademakers R; Josephs KA
    Neurology; 2009 Sep; 73(13):1058-65. PubMed ID: 19786698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of dementia in MCI: combined effect of cerebrovascular disease, volumetric MRI, and 1H MRS.
    Kantarci K; Weigand SD; Przybelski SA; Shiung MM; Whitwell JL; Negash S; Knopman DS; Boeve BF; O'Brien PC; Petersen RC; Jack CR
    Neurology; 2009 Apr; 72(17):1519-25. PubMed ID: 19398707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
    Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
    Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain volumetric deficits in MAPT mutation carriers: a multisite study.
    Chu SA; Flagan TM; Staffaroni AM; Jiskoot LC; Deng J; Spina S; Zhang L; Sturm VE; Yokoyama JS; Seeley WW; Papma JM; Geschwind DH; Rosen HJ; Boeve BF; Boxer AL; Heuer HW; Forsberg LK; Brushaber DE; Grossman M; Coppola G; Dickerson BC; Bordelon YM; Faber K; Feldman HH; Fields JA; Fong JC; Foroud T; Gavrilova RH; Ghoshal N; Graff-Radford NR; Hsiung GR; Huey ED; Irwin DJ; Kantarci K; Kaufer DI; Karydas AM; Knopman DS; Kornak J; Kramer JH; Kukull WA; Lapid MI; Litvan I; Mackenzie IRA; Mendez MF; Miller BL; Onyike CU; Pantelyat AY; Rademakers R; Marisa Ramos E; Roberson ED; Carmela Tartaglia M; Tatton NA; Toga AW; Vetor A; Weintraub S; Wong B; Wszolek ZK; ; Van Swieten JC; Lee SE
    Ann Clin Transl Neurol; 2021 Jan; 8(1):95-110. PubMed ID: 33247623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative multivoxel proton MR spectroscopy study of brain metabolites in patients with amnestic mild cognitive impairment: a pilot study.
    Yang ZX; Huo SS; Cheng XF; Xu ZF; Cao Z; Zeng JX; Xiao YY; You KZ; Chen W; Liu YY; Wu RH
    Neuroradiology; 2012 May; 54(5):451-8. PubMed ID: 21739221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.